- $605.38m
- $422.26m
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
U.S. STOCKS ON THE MOVE-Gold miners, Polestar Automotive, Nvidia
Climb Bio rises after early-stage data for kidney disease drug
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Climb Bio Q2 net loss widens on pipeline advancement
Brief: Climb Bio - Enters Open Market Sale Agreement With Jefferies - SEC Filing
Brief: Climb Bio - Enters Open Market Sale Agreement With Jefferies Dated June 12, 2026 - SEC Filing
Brief: Climb Bio - Announces Initial Phase 1B Data For Budoprutug In Immune Thrombocytopenia
Brief: Climb Bio - Announces Initial Phase 1 Safety Data For CLYM116 - SEC Filing
Brief: Climb Bio - Files For Resale Of Up To 11.6 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-IBM, Lumentum Holdings, TransDigm Group
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi
U.S. STOCKS ON THE MOVE-AxoGen, energy companies, Corning
U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, Veradermics
U.S. STOCKS ON THE MOVE- Kimberly-Clark, JetBlue, Amgen
Climb Bio jumps after $110 mln share placement
U.S. STOCKS ON THE MOVE-UnitedHealth, Intel, Apple
U.S. STOCKS ON THE MOVE-Apple, Intel, Alignment Healthcare